Exogenous administered DL- sodium beta-hydroxybutyrate (beta-OHB) can cross the blood brain barrier. uri icon

Overview

publication date

  • May 1, 2003

Research

keywords

  • 3-Hydroxybutyric Acid
  • Blood-Brain Barrier
  • Brain
  • Hyperinsulinism
  • Hypoglycemia

Identity

Scopus Document Identifier

  • 0037406034

Digital Object Identifier (DOI)

  • 10.1203/01.PDR.0000063370.16142.2F

PubMed ID

  • 12715792

Additional Document Info

volume

  • 53

issue

  • 5